Aligos Therapeutics, Inc. ALGS
Nov 12, 2026, 11:43 AM EST
- YTD
- -77.79%
- 1 year
- -67.91%
ALGS free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-82,940,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -82,940,000 | -2,067,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -80,873,000 | -1,857,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -79,016,000 | 1,316,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -80,332,000 | 36,222,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -116,554,000 | -40,227,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -76,327,000 | -26,774,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -49,553,000 | -40,988,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -8,565,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:01.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.